Brendan P. Eckelman - Nov 1, 2022 Form 4 Insider Report for Inhibrx, Inc. (INBX)

Role
Chief Scientific Officer
Signature
/s/ Kelly D. Deck, attorney-in-fact
Stock symbol
INBX
Transactions as of
Nov 1, 2022
Transactions value $
-$1,340,387
Form type
4
Date filed
11/2/2022, 05:04 PM
Previous filing
Oct 5, 2022
Next filing
Dec 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBX Common Stock Sale -$922K -27.7K -1.24% $33.34 2.21M Nov 1, 2022 By the Eckelman Living Trust dated February 5, 2014 F1, F2, F3
transaction INBX Common Stock Sale -$419K -12.3K -0.56% $33.90 2.2M Nov 1, 2022 By the Eckelman Living Trust dated February 5, 2014 F1, F3, F4
holding INBX Common Stock 160K Nov 1, 2022 By trust F5
holding INBX Common Stock 160K Nov 1, 2022 By trust F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Eckelman Living Trust dated February 5, 2014.
F2 The shares were sold in multiple transactions at prices ranging from $32.68 to $33.67, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 These securities are directly owned by the Eckelman Living Trust dated February 5, 2014. Brendan P. Eckelman is the trustee of the Eckelman Living Trust dated February 5, 2014 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Eckelman Living Trust dated February 5, 2014.
F4 The shares were sold in multiple transactions at prices ranging from $33.68 to $34.47, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F5 These securities are directly owned by a trust, for the benefit of Brendan P. Eckelman's minor son. Brendan P. Eckelman is the trustee of the trust, and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the trust.
F6 These securities are directly owned by a trust, for the benefit of Brendan P. Eckelman's minor daughter. Brendan P. Eckelman is the trustee of the trust, and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the trust.